PBAC Public Summary Document - March 2014

Page last updated: 24 March 2015

Public Summary Documents relating to the March 2014 PBAC meeting.
 

• Aclidinium Bromide, 400 microgram/actuation inhalation: powder for, 60 actuations, Bretaris® Genuair®
• Aflibercept, 2 mg/0.05 mL injection, 1 x 0.05 mL vial and 2 mg/0.05 mL injection, 1 x 0.05 mL syringe, Eylea®
• Betaine, 1 g/g oral liquid: powder for, 180 g, Cystadane®
• Bevacizumab, 100 mg/4 mL injection, 1 x 4mL vial and 400 mg/16 mL injection, 1x16 mL vial, Avastin®, Roche Products Pty Limited *
• Brentuximab Vedotin, 50 mg injection, 1 x 50 mg vial Adcetris®
• Certolizumab Pegol, 200 mg/mL injection, 2 x 1 mL syringes, Cimzia®
• Cinacalcet, tablets, 30 mg, 60 mg and 90 mg, Sensipar®
• Crizotinib, 200 mg capsule, 60 and 250 mg capsule, 60, Xalkori®, Pfizer Australia Pty Ltd *
• Eculizumab, concentrated solution for I.V. infusion, 300 mg in 30 mL, Soliris®
• Erlotinib, 25 mg tablet, 30, 100 mg tablet, 30 and 150 mg tablet, 30, Tarceva®, Roche Products Pty Limited *
• Everolimus (RCC), tablets, 5 mg and 10 mg, Afinitor®, Novartis Pharmaceuticals Australia Pty Ltd *
• Everolimus (pNet), tablets, 5 mg and 10 mg, Afinitor®, Novartis Pharmaceuticals Australia Pty Ltd *
• Fampridine, tablet (modified release), 10 mg, Fampyra®
• Febuxostat, tablet, 80 mg and 120 mg, Adenuric®
• Fentantyl, 100 micrograms/actuation nasal spray, 8 actuations and 400 micrograms/actuation nasal spray, 8 actuations, PecFent®
• Fentantyl, tablet: sublingual, 100 microgram, 200 microgram and 400 microgram, Abstral®
• Fluticasone Furoate and Vilanterol Trifenatate, 30 actuations Breo® Ellipta® GlaxoSmithKline Australia Pty Ltd (Asthma)*
• Fluticasone Furoate and Vilanterol Trifenatate, dry powder inhaler, fluticasone furoate 100 microgram/actuation + vilanterol trifenatate 25 microgram/actuation, Breo® Ellipta®, GlaxoSmithKline Australia Pty Ltd (COPD) *
• Follitropin Alfa and Lutropin Alfa, injection, 150 IU + 75 IU, Pergoveris®
• Indacaterol + Glycopyrronium, indacaterol 110 microgram + glycopyrronium 50 microgram inhalation: powder for, Ultibro Breezhaler 110/50®, Novartis Pharmaceuticals Australia Pty Ltd *
• Infliximab, 100 mg injection, 1 x 100 mg vial, Remicade®
• Ivacaftor, 150 mg tablet, 56, Kalydeco®
• Ivermectin, 3 mg tablet, Stromectol®
• Levonorgestrel, intrauterine system, 13.5 mg, Jaydess®
• Lurasidone hydrochloride, 40 mg tablet, 30 and 80 mg tablet, 30 Latuda®
• Macitentan, tablet, 10mg, Opsumit®
• Paclitaxel-Nanoparticle Albumin Bound, 100 mg injection, 1 x 100 mg vial, 250 mg injection, 1 x 250 mg vial, Abraxane®
• Pertuzumab, 420 mg/14 mL injection, 1 x 14 mL vial, Perjeta®, Roche Products Pty Ltd *
• Progesterone, pessary, 100 mg, Endometrin®
• Ranibizumab, solution for intravitreal injection, 2.3 mg in 0.23 mL, Lucentis®, Novartis Pharmaceuticals Australia Pty Ltd *
• Riociguat, 500 microgram tablet, 42 and 84, 1 mg tablet, 42 and 84, 1.5 mg tablet, 42 and 84, 2 mg tablet, 42 and 84, and 2.5 mg tablet, 42 and 84, Adempas®
• Trametinib, 0.5 mg tablet, 30 and 2 mg tablet, 30 Mekinist® GlaxoSmithKline Australia Pty Ltd *
• Trastuzumab Emtansine, injections, 100 mg vial and 160 mg vial, Kadcyla®, Roche Products Pty Ltd *
• Umeclidinium Bromide and Vilanterol Trifenatate, umeclidinium bromide 62.5 microgram/actuation + vilanterol trifenatate 25 microgram/actuation inhalation: powder for, AnoroTM Ellipta®, GlaxoSmithKline Australia Pty Ltd *

• Varenicline, tablets, 500 microgram and 1 mg (as tartrate) (titration pack), tablets, 1 mg (as tartrate), Champix®, Pfizer Australia Pty Ltd. *
• Voriconazole, 50 mg tablet, 56, 200 mg tablet, 56 and 40 mg/mL oral liquid: powder for, 70 mL, Vfend®, Pfizer Australia Pty Ltd *
• Zoster virus vaccine live, 0.65 mL injection, prefilled syringe, Zostavax®

* For these PSDs, please refer to the Pilot for new process to redact confidential information